© 2025 WGCU News
PBS and NPR for Southwest Florida
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

France Bars Use Of Hydroxychloroquine In COVID-19 Cases

France's health ministry says there is no proof that hydroxychloroquine helps patients – and it says recent studies have found it could cause other health risks.  A box of hydroxychloroquine, under the brand name Plaquenil, is seen in a pharmacy in Paris.
France's health ministry says there is no proof that hydroxychloroquine helps patients – and it says recent studies have found it could cause other health risks. A box of hydroxychloroquine, under the brand name Plaquenil, is seen in a pharmacy in Paris.

The French government is revoking a decree that had allowed hospitals to prescribe hydroxychloroquine in some COVID-19 cases, saying there is no proof that it helps patients — and citing data that shows it could cause heart problems and other health risks.

"This molecule must not be prescribed for patients affected by COVID-19," the Ministry of Solidarity and Health said as it announced the change.

The move to bar hospitals from prescribing the drug for coronavirus patients comes two days after the World Health Organization halted clinical trials of hydroxychloroquine as a treatment for COVID-19. The WHO cited a study published in The Lancet, that had found no benefit from the drug and reported a higher mortality rate for hospitalized patients and "an increased frequency of ventricular arrhythmias."

France's health ministry had approved hydroxychloroquine for emergency prescriptions in COVID-19 cases in late March.

As France 24 reports, that's when French researcher Didier Raoult, who has been an insistent proponent of hydroxychloroquine, said he had successfully treated COVID-19 patients using the controversial drug in combination with azithromycin. But the health ministry says recent studies show the treatment can produce "cardiac toxicity, particularly in combination with azithromycin."

Researchers continue to evaluate the possible use of hydroxychloroquine, which is used to treat malaria and lupus, to fight the coronavirus, with at least two studies underway in the U.S. As NPR's Joe Palca reports, the drug has been found to be able to prevent replication of the coronavirus.

President Trump has frequently touted hydroxychloroquine as a treatment for COVID-19 — and last week, he said that he was taking doses of both hydroxychloroquine and zinc to protect against the coronavirus, despite warnings about the drug.

"I've taken it for about a week and a half now. And I'm still here," he said.

Both the Food and Drug Administration and the National Institutes of Health have warned of health risks involved with people taking hydroxychloroquine hoping to prevent or treat COVID-19.

On the same day Trump said he was taking the drug, the FDA issued a list of its potentially dangerous side effects:

"Side effects of hydroxychloroquine include irreversible retinal damage, cardiac effects (including cardiomyopathy and QT prolongation), worsening of psoriasis and porphyria, proximal myopathy and neuropathy, neuropsychiatric events, and hypoglycemia."

Copyright 2020 NPR. To see more, visit https://www.npr.org.

Bill Chappell is a writer and editor on the News Desk in the heart of NPR's newsroom in Washington, D.C.
Trusted by over 30,000 local subscribers

Local News, Right Sized for Your Morning

Quick briefs when you are busy, deeper explainers when it matters, delivered early morning and curated by WGCU editors.

  • Environment
  • Local politics
  • Health
  • And more

Free and local. No spam. Unsubscribe anytime.

More from WGCU
  • A local public transit program is being called a success, after two years of a trial run.LeeTran said the ULTRA On Demand Transit program is working, and may be expanded.
  • The boardwalk connecting Florida Gulf Coast University’s South Village residential area to the academic core is temporarily closed to pedestrian use from dusk to dawn. The closure is due to an act of vandalism that damaged the lighting system, creating hazardous conditions overnight.
  • FGCU graduate 22-year-old Zoey Carter walked for her mother Wednesday.Jessica Carter -- her mother -- died at age 49 from breast cancer. “I'm walking here today in honor of my mom. She passed away last year after battling breast cancer for four years," she said. "We came here together two years ago, and she did the walk. So I'm finally back, just in her honor.” Zoey Carter fought back tears but gathered the strength to attend the Making Strides Against Breast Cancer Walk. She joined along with several thousand Southwest Floridians, awash in a sea of pink, at Paradise Coast Sports Complex in Collier County.